Lung Cancer Trial, By Invitation NCT06610240 Sponsor: Shanghai Chest Hospital Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, By Invitation

NCT06610240
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People diagnosed with Stage I, II, or III non-small cell lung cancer (a common type of lung cancer), confirmed through laboratory testing of tissue or cell samples, based on a specific international staging system (the 8th edition AJCC system).
  • People who have had surgery to remove their lung cancer with the goal of curing it (known as radical surgery).
  • People who received treatment before their lung cancer surgery — such as chemotherapy, targeted therapy, or immunotherapy, either on their own or in combination.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have had another type of cancer in the past, unless that cancer was completely cleared up at least two years before their lung cancer surgery and no further treatment was needed for it.
  • People whose medical records are missing important information about their condition and treatment, such as cancer stage, cancer type, the treatments given before surgery, how the cancer responded to those treatments, or scan results after pre-surgery treatment.
  • People who were enrolled in another clinical trial involving an anti-cancer drug where the treatment being given was not known or disclosed.
  • People who had surgery, radiation therapy, or other systemic cancer treatments for their lung cancer before the surgery this trial is focused on, including procedures such as radiofrequency ablation.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 1 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
Shanghai Chest Hospital
Registry
ClinicalTrials.gov
Start date
1 November 2024
Est. completion
31 May 2025

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇨🇳 China

Primary endpoints

event-free survival; overall survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 1 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov